Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Science. 2013 Mar 22;339(6126):1426-9. doi: 10.1126/science.1229159.
Toll-like receptor 7 (TLR7) and TLR8 recognize single-stranded RNA and initiate innate immune responses. Several synthetic agonists of TLR7-TLR8 display novel therapeutic potential; however, the molecular basis for ligand recognition and activation of signaling by TLR7 or TLR8 is largely unknown. In this study, the crystal structures of unliganded and ligand-induced activated human TLR8 dimers were elucidated. Ligand recognition was mediated by a dimerization interface formed by two protomers. Upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity. The loop between leucine-rich repeat 14 (LRR14) and LRR15 was cleaved; however, the N- and C-terminal halves remained associated and contributed to ligand recognition and dimerization. Thus, ligand binding induces reorganization of the TLR8 dimer, which enables downstream signaling processes.
Toll 样受体 7(TLR7)和 TLR8 识别单链 RNA 并启动先天免疫反应。几种 TLR7-TLR8 的合成激动剂显示出新颖的治疗潜力;然而,TLR7 或 TLR8 的配体识别和信号激活的分子基础在很大程度上仍是未知的。在这项研究中,阐明了未配体结合和配体诱导激活的人 TLR8 二聚体的晶体结构。配体识别是由两个原聚体形成的二聚化界面介导的。在配体刺激下,TLR8 二聚体被重新组织,使得两个 C 末端接近。富含亮氨酸重复 14(LRR14)和 LRR15 之间的环被切割;然而,N-和 C-末端仍然保持关联,并有助于配体识别和二聚化。因此,配体结合诱导 TLR8 二聚体的重排,从而使下游信号转导过程成为可能。